Skip to main content Accessibility help
×
Home
Hostname: page-component-cf9d5c678-h2mp8 Total loading time: 0.234 Render date: 2021-07-30T08:59:30.445Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Immunological changes in a case of Marchiafava Bignami disease: response to amineptine treatment

Published online by Cambridge University Press:  16 April 2020

T Humbert
Affiliation:
Service de Psychiatrie, Hôpital d'Alès, 30100 Alés en Cévennes, France
JP Bureau
Affiliation:
Laboratoire de Biologie Cellulaire et d'Immunogénétique, Faculté de Médecine, 34000Montpellier, France
P Chabrand
Affiliation:
Service de Psychiatrie, Hôpital de Nîmes, 30000Nîmes, France
Get access

Summary

Marchiafava-Bignami disease (MBD) is a rare complication of chronic alcoholism. We describe a regressive form of MBD in which a primary decrease in CD4+ cells was improved by amineptine treatment. No significant change in the CD4 : CDS ratio was observed in a few major depressed subjects receiving this drug.

Type
Case report
Copyright
Copyright © Elsevier, Paris 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alavi, AHirschj, LJStudies of central nervous system disorders with single-photon emission computed tomography and positron emission tomography: evolution over the past 2 decades Semin Nucl Med 21 1991; 5881CrossRefGoogle ScholarPubMed
Bagasra, OForman, LFunctionnal analysis of lymphocyte subpopulations in experimental cocaine abuse. I. Dose dependent activation of lymphocyte subsets. Clin Exp Immunol 1989; 77: 289–93Google Scholar
Barnéoud, PNeveu, PJVitiello, SMormède, PLe Moal, MBrain neocortex immunomodulation in rats. Brain Res 1988; 474: 394–8CrossRefGoogle ScholarPubMed
Baron, RHeuser, KMarioth, GMarchiafava-Bignami disease with recovery diagnosed by CT and MRI: demyelisation affects several CNS structures. J Neurol 1989; 236: 364–6CrossRefGoogle Scholar
Bourrat, CTomassi, MBochu, MKopp, NMaisch, SX-ray scanning in Marchiafava-Bignami disease. Rev Neurol 1984; 140: 426–31Google ScholarPubMed
Delangre, TMannequin, DClavier, EDenis, PMihout, BSamson, MMaladie de Marchiafava-Bignami d'évolution favorable. Rev Neurol 1986; 142: 933–6Google Scholar
Delay, JBrion, SEscourolle, RSanchez, ARapports entre la dégénérescence du corps calleux de Marchiafava-Bignami et la sclérose laminaire corticale de Morel (à propos de 5 observations anatomo-cliniques). Encéphale 1959; 4: 281311Google Scholar
De Micco, CToga, MLe statut immunitaire du système nerveux central. Rev Neurol 1988; 144: 776–88Google Scholar
Evans, DLPedersen, CAFolds, JDMajor depression and immunity: preliminary evidence of decreased natural killer cell populations Prog Neuropsycopharmacol Biol Psychiatry 12 1988 739–48CrossRefGoogle ScholarPubMed
Ferguson, RMSchmidtke, JRSimmons, RLBergsma, DGoldstein, ANeurochemical and Immunological Components of Schizophrenia 18 New York: Alan R Liss, 1978; 379402Google Scholar
Heepe, PNemeth, LBrune, FGrant, JWKleihues, PMarchiafava-Bignami disease. A correlative computed tomography and morphological study. Eur Arch Psychiatr Neurol Sci 1988; 237: 74–910.1007/BF00382370CrossRefGoogle ScholarPubMed
Humbert, TDe Guilhermier, PMaktouf, CGrasset, GLopez, FMChabrand, PMarchiafava-Bignami disease. A case studied by structural and functional brain imaging. Eur Arch Psychiatry Clin Neurosci 1992; 242: 6971CrossRefGoogle ScholarPubMed
Irwin, MCaldwell, CSmith, TLBrown, SSchuckit, MAGillin, JCMajor depressive disorder, alcoholism, and reduced natural killer cell cytotoxicity. Arch Gen Psychiatry 1990; 47: 713–9CrossRefGoogle ScholarPubMed
Kempinsky, WHExperimental study of distant effects of acute focal brain injury. A study of diaschisis. Arch Neurol Psychiatry 1958; 79: 376–89CrossRefGoogle ScholarPubMed
Leboyer, MOsherson, DNNosten, MRoubertoux, PIs autism associated with anomalous dominance?. J Autism Dev Disord 1988; 18: 539–4910.1007/BF02211872CrossRefGoogle ScholarPubMed
Marchiafava, EBignami, ASopra un alterzione del corpo calloso osservata in sogetti alcoolisti. Riv Patol Nerv Ment 1903; 8: 544–9Google Scholar
Meuer, SCSchlossmann, SFReinherz, ELClonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompa-tibility complex regions Proc Natl Acad Sci USA 79 1982; 4395–9CrossRefGoogle Scholar
Meyrignac, CBokobza, MCesaro, PDegos, JDContribution de l'image par résonance magnétique au diagnostic de la maladie de Marchiafava-Bignami. Presse Médicale 1987; 16: 1863–4Google Scholar
Neveu, PJCerebral neocortex modulation of immune functions. Life Sci 1988; 42: 1917–23CrossRefGoogle ScholarPubMed
Nevue, PJLatéralisation cérébrale et réponse immunitaire L'Encéphale XV 1989 405–8Google Scholar
Ou, DDShen, MLLuo, YDEffects of cocaine on the immune system of Balc/C mice. Clin Immunol Immunopathol 1989; 52: 305–12CrossRefGoogle Scholar
Schleifer, SJKeller, SEBond, RNCohen, JStein, MMajor depressive disorder and immunity. Arch Gen Psychiatry 1989; 46: 81–710.1001/archpsyc.1989.01810010083011CrossRefGoogle ScholarPubMed
Warren, RPMargaretten, NCPace, NCImmune abnormalities in patients with autism. J Autism Dev Disord 1986; 16: 189–9710.1007/BF01531729CrossRefGoogle ScholarPubMed
Wik, GBorg, SSjorgen, IPositron emission tomography determination of regional cerebral glucose metabolism in alcohol-dependent men and healthy controls using 11C-glucose. Acta Psychiatr Scand 1988; 78: 234–41CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Immunological changes in a case of Marchiafava Bignami disease: response to amineptine treatment
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Immunological changes in a case of Marchiafava Bignami disease: response to amineptine treatment
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Immunological changes in a case of Marchiafava Bignami disease: response to amineptine treatment
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *